Trial Information
Adipocytokines as Predictors of the Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia
Inclusion Criteria:
- ALL diagnosis
- five years after completion of treatment
- leukemia free during research
Exclusion Criteria:
- ongoing chemotherapy and radiotherapy
Type of Study:
Observational
Study Design:
Observational Model: Cohort
Principal Investigator
Yael Weintraub, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Tel Aviv University
Authority:
Israel: Israeli Health Ministry Pharmaceutical Administration
Study ID:
SHEBA-07-4861-YW-CTIL
NCT ID:
NCT00566566
Start Date:
January 2008
Completion Date:
December 2008
Related Keywords:
- Leukemia
- Metabolic Syndrome X
- adipocytokines
- inflammatory markers
- cardiovascular disease
- diabetes mellitus
- Leptin
- Leukemia
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Metabolic Syndrome X